How to Choose a PRP Kit for Your Practice

Choosing a PRP kit isn’t a generic medical-supply decision, it’s a clinical procurement call where biology, regulation, workflow, and economics all collide. The right kit for an orthopedic sports-medicine practice is the wrong kit for an aesthetic dermatology clinic, and the cost of picking poorly shows up in disappointing outcomes long after the disposable invoice is paid. Start from the indication you’ll actually treat, and let leukocyte profile, concentration target, and evidence drive the shortlist before price ever enters the conversation.

• Indication first: Match the kit’s leukocyte and concentration profile to the specific condition you treat, not to a generic “PRP” label.
• Leukocyte profile: LR-PRP for chronic tendinopathy, LP-PRP for osteoarthritis, aesthetics, and hair restoration.
• Total cost envelope: Disposables run $30 to over $300 per case, centrifuges from under $2,000 to over $15,000, patient fees $250 to $2,000 cash-pay.
• Workflow reality: Plan for 30 to 45 minutes chair time per case from draw through injection, plus real training and ongoing technique discipline.

What clinical indications and patient populations drive PRP kit selection for a given practice?

Indication is the gravitational center of kit selection because the biology you’re trying to influence shifts dramatically from one application to the next. A kit that’s perfect for chronic tendinopathy can underperform badly in an arthritic knee, and the practices that get the best outcomes are the ones that pick the kit for the case mix, not the case mix for the kit.

How does leukocyte content (LR-PRP vs LP-PRP) determine which PRP kit is appropriate for a specific indication?

Leukocyte content is the single biggest biological variable separating one PRP preparation from another, and it’s the line the modern literature has organized itself around. The white cells in LR-PRP release matrix-degrading enzymes and inflammatory cytokines on activation, which helps stalled tendons heal but punishes inflamed joints and aesthetic skin.

What centrifugation methods do PRP kits use and how do they affect platelet concentration, yield, and final product quality?

Centrifugation methodology is what a kit can actually deliver, and the two variables that decide everything are the number of spin cycles and the separation mechanism that isolates platelets from the rest of the blood. Speed and operator-friendliness sit on one end of that spectrum, peak concentration and tighter control sit on the other, and almost no kit gives you both.

What anticoagulants and activation methods are used in PRP preparation and how do they influence clinical outcomes?

Anticoagulant and activation choices look like small details on a spec sheet, but they shape both the harvest and how the platelets behave when they hit the tissue. The modern field has converged on a few defaults for good biological reasons, and you should know why before letting a sales rep tell you their proprietary twist is better.

• ACD-A is the standard anticoagulant: Chelates calcium gently, preserves platelet morphology and growth-factor responsiveness, and prevents premature activation in the tube.
• Heparin is avoided: Activates platelets prematurely and interferes with downstream coagulation at the injection site.
• Non-activated injection dominates in vivo use: Endogenous collagen and tissue thromboplastin trigger physiologic activation in joints, tendons, and dermis, which is the orthopedic and aesthetic default.
• Calcium chloride or autologous thrombin activation: Reserved for ex vivo applications like wound dressings, fibrin glues, and dental graft preparations where you need an immediate growth-factor burst.

What FDA regulations and 510(k) clearances apply to PRP kits and what do those clearances actually permit?

The gap between what a 510(k) actually clears and what a PRP kit gets used for in the real world is wider than most clinicians realize, and that gap is your regulatory and medico-legal exposure. The FDA cleared the device to prepare PRP, not to treat anything specific, and conflating those two in your marketing or consent forms is where practices get into trouble.

1. Read the actual 510(k) summary, not the brochure: The cleared indication is almost always preparation of autologous platelet concentrate for mixing with bone graft material during orthopedic, dental, or maxillofacial surgery.
2. Recognize most therapeutic uses are off-label: Tendinopathy, OA, hair restoration, facial rejuvenation, and sexual-health applications all sit outside cleared language, which is legal under physician judgment but shifts the burden onto you.
3. Confirm HCT/P minimal-manipulation status: Standard centrifugation and autologous reinjection keep PRP out of biologic-licensure territory, but proprietary stimulators or growth-factor adjuvants can push it across the line.
4. Document off-label use in informed consent: Spell out that FDA clearance addresses device safety for PRP preparation, not therapeutic efficacy for any specific condition.
5. Avoid manufacturer marketing language that overstates claims: Repeating an “FDA cleared” claim in patient-facing materials in a way that implies therapeutic approval is exactly the framing that has drawn enforcement attention.

What does PRP treatment cost per session and what financial factors determine practice ROI on a PRP kit?

The economics span a far wider range than most outsiders assume, and the gap between best-case pro formas and real-world margins is where most adoption mistakes happen. Case volume drives break-even far more than disposable price does, but only if your indication, fee structure, and workflow are honest about what the local market will actually pay.

What clinical evidence and manufacturer support should be evaluated when comparing competing PRP kits?

Evaluating evidence and support is the discipline most buyers skip, and it’s responsible for a huge share of regretted kit purchases. There are two separate evidence questions you need to ask, and conflating them is the single most common evaluation mistake.

1. Separate therapy evidence from kit evidence: Trials proving “PRP works for X” don’t prove “this specific kit works for X,” because preparation characteristics vary so widely between systems.
2. Pull therapy-level evidence from PubMed: Look for RCTs and meta-analyses, weighted by sample size, blinding quality, and outcome measure validity, and apply tighter scrutiny to manufacturer-funded work.
3. Demand kit-level characterization data: Independent third-party measurements of platelet concentration factor, leukocyte content, RBC contamination, and operator-to-operator yield consistency, ideally published rather than handed to you on a glossy sheet.
4. Audit training and support depth: In-person training with hands-on technique and ongoing case review is a different product than a one-hour rep visit, and the difference shows up in your outcomes for years.
5. Test responsiveness before you buy: Sales-rep response time, disposable replacement lead times, and clinical-hotline availability matter for daily operations far more than the polished initial demo suggests.

What equipment, training, and workflow requirements come with adopting a PRP kit in a clinical practice?

The operational footprint of a PRP program is almost always underestimated during evaluation, and workflow fit can quietly sink a kit regardless of how well its biology performs. Map the actual case path through your practice before you sign anything, because the manufacturer’s idealized timeline rarely survives contact with a real clinic day.

What common pitfalls and quality risks should be avoided when selecting and using a PRP kit?

The pitfalls cluster into a small set of recurring patterns that experienced practitioners learn to recognize, and almost every disappointed PRP buyer has fallen into one of them. The good news is they’re all preventable if you know what to look for before signing the purchase order.